Cargando…

Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches

Gastric cancer (GC) remains one of the most common deadly malignancies worldwide. Recently, several targeted therapeutics for treating unresectable or metastatic GC have been developed. Comprehensive characterization of the molecular profile and of the tumor immune microenvironment of GC has allowed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Sangjoon, Park, Sujin, Kim, Hyunjin, Kang, So Young, Ahn, Soomin, Kim, Kyoung-Mee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945014/ https://www.ncbi.nlm.nih.gov/pubmed/35327345 http://dx.doi.org/10.3390/biomedicines10030543

Ejemplares similares

Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden
por: Kim, Hyunjin, et al.
Publicado: (2022)

Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer
por: Shin, Minkyue, et al.
Publicado: (2023)

MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015)

Artificial Intelligence in the Pathology of Gastric Cancer
por: Choi, Sangjoon, et al.
Publicado: (2023)

A Standardized Pathology Report for Gastric Cancer: 2nd Edition
por: Park, Young Soo, et al.
Publicado: (2023)

A standardized pathology report for gastric cancer: 2nd edition
por: Park, Young Soo, et al.
Publicado: (2023)

Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma
por: Lee, Sun-Mi, et al.
Publicado: (2012)

DNA-protein biomarkers for immunotherapy in the era of precision oncology
por: Kim, Binnari, et al.
Publicado: (2021)

Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer
por: Kim, Binnari, et al.
Publicado: (2023)

Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)

Correlation between MEK signature and Ras gene alteration in advanced gastric cancer
por: Ahn, Soomin, et al.
Publicado: (2017)

Neurofibroma of the Colon: A Diagnostic Mimicker of Gastrointestinal Stromal Tumor
por: Ahn, Soomin, et al.
Publicado: (2016)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
por: Kang, So Young, et al.
Publicado: (2013)

Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer
por: Kim, Jin-Chul, et al.
Publicado: (2021)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Deep learning-based virtual cytokeratin staining of gastric carcinomas to measure tumor–stroma ratio
por: Hong, Yiyu, et al.
Publicado: (2021)

PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression
por: Kim, Binnari, et al.
Publicado: (2020)

MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
por: Lee, Ji Yun, et al.
Publicado: (2016)

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors
por: Kim, Hana, et al.
Publicado: (2021)

Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion
por: Lee, Sun-Mi, et al.
Publicado: (2014)

Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
por: Kim, Hyoung Woo, et al.
Publicado: (2020)

A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth
por: Park, Jihyun, et al.
Publicado: (2016)

To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients
por: Lee, Hansang, et al.
Publicado: (2016)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Exuberant squamous metaplasia of the gastric mucosa in a patient with gastric adenocarcinoma
por: Ahn, Sangjeong, et al.
Publicado: (2015)

CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
por: Choi, Eun-Seok, et al.
Publicado: (2017)

Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples
por: Ahn, Soomin, et al.
Publicado: (2013)

Exome Sequencing Identifies Early Gastric Carcinoma as an Early Stage of Advanced Gastric Cancer
por: Kang, Guhyun, et al.
Publicado: (2013)

Expression of CD274 mRNA Measured by qRT-PCR Correlates With PD-L1 Immunohistochemistry in Gastric and Urothelial Carcinoma
por: Kang, So Young, et al.
Publicado: (2022)

Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers
por: Kang, So Young, et al.
Publicado: (2022)

Accuracy of an administrative database for pancreatic cancer by international classification of disease 10(th) codes: A retrospective large-cohort study
por: Hwang, Young-Jae, et al.
Publicado: (2019)

Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa
por: Kim, Binnari, et al.
Publicado: (2020)

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)

The proteomics approach to find biomarkers in gastric cancer.
por: Ryu, Jin-Woo, et al.
Publicado: (2003)

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017)

NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer
por: Das, Kakoli, et al.
Publicado: (2016)

Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches
por: Fu, Yan, et al.
Publicado: (2018)

RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
por: Kim, Hee Kyung, et al.
Publicado: (2019)

MicroRNA Expression Profiles in Gastric Carcinogenesis
por: Hwang, Jinha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c2dr7f551gofq638ndnec8ib99